Stock Analysis

Mesoblast (ASX:MSB) has reached a markedly different stage of development after years in which itsInvestmentcase depended largely onClinical Trialsand regulatory outcomes.

Imdex (ASX:IMD) has established itself as a differentiated mining-technology company by supplying the tools, sensors, software and data systems used across exploration and resource definition.

Viva Leisure (ASX:VVA) is one of the ASX's more direct exposures to the health and fitness economy, running a national network of health clubs through a mix of corporate-owned and franchised sites. As consumers continue to prioritise wellbeing and gym participation, the central question …

Paradigm Biopharmaceuticals (ASX:PAR) remains one of the ASX's more binary healthcare stories: a clinical-stage biotech whose value is tied largely to a single drug programme and its progression through late-stage trials. The market is effectively waiting on data and funding clarity rather than pricing …

Finbar Group (ASX:FRI) is a long-established Western Australian apartment developer whoseEarningscan move sharply between reporting periods because of the timing of project completions and settlements.

Waratah Minerals (ASX:WTM) is developing its exploration story around the Spur Project in central New South Wales, where drilling has continued to test and expand gold mineralisation within the Macquarie Arc.

Motio (ASX:MXO) is a micro-cap that sits outside the mainstream of investor attention, but its latest full-year result provides a useful look at how a small, diversified mediaBusinessis trying to turn steady revenue into more consistent profit. Motio describes itself as an audience-experience and …